San Diego, CA /PRNewswire/ -- Bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) MicroConstants announced today the successful completion of a five-day inspection by the United States Food and Drug Administration (FDA) for compliance with Good Laboratory Practice (GLP) regulations.

On September 20, 2012, an investigator from the FDA visited MicroConstants' San Diego facility for a routine inspection to assess the CRO's overall compliance with GLP regulations. During the visit, the investigator toured the facility and laboratory areas and reviewed several method validations, three sample analysis projects, and a pharmacokinetic analysis report. Upon completion of the inspection, the investigator reported zero findings, observations, or recommendations.

SAN FRANCISCO--(BUSINESS WIRE)--

PRC Clinical™, a Contract Research Organization (CRO) in the San Francisco Bay Area providing full-service clinical trial management services, announced today that it has been awarded a Phase IIb study in an orphan-status therapeutic indication. Enrollment is expected at more than 50 study centers in the US and Canada.

Research Triangle Park – Copernicus Group IRB (CGIRB), a leading independent institutional review board, announced today that Corporate Trainer Sydney Douglas will be speaking at this week’s Barnett Clinical Summit in Cambridge, Mass.

The four-day summit, which begins today, is a premier information-sharing forum covering issues of key importance to clinical research professionals. The event includes formal presentations from leading experts, case studies, breakout discussion groups and workshops.